Status:
UNKNOWN
Lidocaine for Pain Control During Intrauterine Device Insertion
Lead Sponsor:
Ain Shams University
Conditions:
IUD Insertion Complication
Eligibility:
FEMALE
18-55 years
Phase:
PHASE4
Brief Summary
Despite being the most common method of contraception, the use of intrauterine devices (IUDs) is limited by the associated pain during insertion. Many pharmacologic interventions had been studied for ...
Eligibility Criteria
Inclusion
- Multiparous women.
- Over 18 years of age and eligible for IUD insertion.
- Application of IUD will be done in postmenstrual period.
Exclusion
- Null parity. 2. History of failed intrauterine device insertion (uterine perforation, acute expulsion).
- 3\. Copper allergy. 4. Uterine anomaly. 5. Post-partum endometritis or septic abortion in the past three months. 6. Untreated cervicitis/vaginitis, including bacterial vaginosis. 7. Immunosuppression. 8. History of lidocaine ,prilocaine allergy. 9. Analgesic or anxiolytic use within the last 24 hours before the procedure. 10. Wilson's disease. 11. Suspicion of pregnancy. 12. Untreated abnormal uterine bleeding.
Key Trial Info
Start Date :
December 3 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 10 2019
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT03362905
Start Date
December 3 2017
End Date
January 10 2019
Last Update
December 5 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.